Workflow
Edelson Lechtzin LLP
icon
Search documents
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Humana Inc. (NYSE: HUM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
GlobeNewswire News Room· 2025-06-06 22:13
Company Overview - Humana Inc. is a for-profit health insurance company that provides Medicare Advantage, individual and group insurance, pharmacy benefit management, and integrated care services through its CenterWell network [3] Allegations of Wrongdoing - The Department of Justice filed a False Claims Act complaint against Humana on May 1, 2025, alleging that from 2016 to at least 2021, the company paid illegal kickbacks to health insurance brokers for enrollments into its Medicare Advantage plans [4] Market Reaction - Following the announcement of the DOJ lawsuit, Humana's stock price fell by $6.20 per share, or 2.36%, closing at $256.04 per share on May 1, 2025 [5]
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of SelectQuote, Inc. (NYSE: SLQT) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
GlobeNewswire News Room· 2025-06-06 21:42
Company Overview - SelectQuote is a direct-to-consumer insurance platform that offers health, life, auto, and home insurance policies, as well as medication management services through its SelectRx pharmacy division [3] Allegations and Legal Issues - The Department of Justice filed a False Claims Act complaint against SelectQuote on May 1, 2025, alleging the company received millions of dollars in kickbacks from Humana in exchange for specific Medicare Advantage plan enrollments [4] - The complaint claims SelectQuote maintained a sales division that exclusively offered Humana policies and directed a significant portion of its business to Humana [4] Market Reaction - Following the filing of the complaint, SelectQuote's stock price fell by $0.61 per share, or 19.2%, closing at $2.56 per share on May 1, 2025 [5]
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Fulgent Genetics, Inc. (NASDAQ: FLGT) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
GlobeNewswire News Room· 2025-05-28 22:10
Company Overview - Fulgent Genetics, Inc. is a biotechnology company that specializes in diagnostic and genetic laboratory testing services and develops pharmaceutical treatments for various diseases and medical conditions [3] Allegations and Investigations - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving Fulgent, stemming from allegations of providing potentially misleading business information to investors [1] - On February 28, 2025, Fulgent disclosed in its annual report that it received a civil investigative demand from the U.S. Department of Justice related to potential false claims submitted under the federal COVID-19 testing program for uninsured individuals [4] Market Reaction - Following the disclosure of the civil investigative demand, Fulgent's stock price declined by $0.41 per share, or approximately 2.61%, closing at $15.28 per share on March 3, 2025 [5]
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Nevro Corp. Customers Whose Data May Have Been Compromised
GlobeNewswire News Room· 2025-04-10 16:44
Core Viewpoint - Nevro Corp. is under investigation for potential data privacy violations following a network breach that may have compromised sensitive personal information of individuals [1][3][5]. Company Overview - Nevro Corp. is a medical device company based in Redwood City, California, recognized for its HFX spinal cord stimulation (SCS) platform [2]. Incident Details - On or around December 1, 2024, Nevro detected suspicious activity on its network, leading to an investigation that revealed unauthorized access to sensitive personal information between November 21, 2024, and December 1, 2024 [3]. Compromised Information - The types of personal information that may have been accessed include names, Social Security numbers, driver's license numbers, financial information (account numbers or credit/debit card numbers), medical information, and health insurance information [4][8]. Legal Action - Edelson Lechtzin LLP is investigating a class action lawsuit to seek legal remedies for individuals whose sensitive personal data may have been compromised due to the data breach at Nevro [5].
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Legacy Professionals LLP Customers Whose Data May Have Been Compromised
Globenewswire· 2025-03-06 19:58
Core Points - Legacy Professionals LLP is under investigation for data privacy violations following a data breach that occurred in April 2024 [1][3][5] - The firm filed a Notice of Data Breach with the Attorney General of Maine on February 27, 2025, indicating that personal information may have been compromised [3][5] - Edelson Lechtzin LLP is leading a class action lawsuit to seek legal remedies for affected customers [5] Company Overview - Legacy Professionals LLP is a certified public accounting firm that specializes in serving employee benefit plans, labor organizations, and nonprofit entities [2] Incident Details - Suspicious activity was detected within Legacy Professionals' computer network in April 2024, prompting an internal investigation [3] - The types of personal information that may have been compromised include names, Social Security numbers, and driver's license or state ID numbers [4][8] Legal Actions - Edelson Lechtzin LLP is investigating claims related to the data breach and is encouraging affected individuals to join the class action lawsuit [1][5]